RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity

Sci Adv. 2020 May 29;6(22):eaaz3865. doi: 10.1126/sciadv.aaz3865. eCollection 2020 May.

Abstract

Distinct lineages of T cells can act in response to various environmental cues to either drive or restrict immune-mediated pathology. Here, we identify the RNA binding protein, poly(C)-binding protein 1 (PCBP1) as an intracellular immune checkpoint that is up-regulated in activated T cells to prevent conversion of effector T (Teff) cells into regulatory T (Treg) cells, by restricting the expression of Teff cell-intrinsic Treg commitment programs. This was critical for stabilizing Teff cell functions and subverting immune-suppressive signals. T cell-specific deletion of Pcbp1 favored Treg cell differentiation, enlisted multiple inhibitory immune checkpoint molecules including PD-1, TIGIT, and VISTA on tumor-infiltrating lymphocytes, and blunted antitumor immunity. Our results demonstrate a critical role for PCBP1 as an intracellular immune checkpoint for maintaining Teff cell functions in cancer immunity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA-Binding Proteins / metabolism
  • Humans
  • Lymphocyte Activation
  • Lymphocytes, Tumor-Infiltrating
  • Neoplasms* / metabolism
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism
  • T-Lymphocytes, Regulatory*

Substances

  • DNA-Binding Proteins
  • PCBP1 protein, human
  • RNA-Binding Proteins